206 related articles for article (PubMed ID: 19585292)
1. An evaluation of monitoring practices in patients on second generation antipsychotics.
Nguyen D; Brakoulias V; Boyce P
Australas Psychiatry; 2009 Aug; 17(4):295-9. PubMed ID: 19585292
[TBL] [Abstract][Full Text] [Related]
2. Effects of a 10-week weight control program on obese patients with schizophrenia or schizoaffective disorder: a 12-month follow up.
Chen CK; Chen YC; Huang YS
Psychiatry Clin Neurosci; 2009 Feb; 63(1):17-22. PubMed ID: 19067997
[TBL] [Abstract][Full Text] [Related]
3. [Prescribing patterns of antipsychotics in 13 French psychiatric hospitals].
Bret P; Bret MC; Queuille E
Encephale; 2009 Apr; 35(2):129-38. PubMed ID: 19393381
[TBL] [Abstract][Full Text] [Related]
4. Metabolic monitoring of patients prescribed second-generation antipsychotics.
Dhamane AD; Martin BC; Brixner DI; Hudson TJ; Said Q
J Psychiatr Pract; 2013 Sep; 19(5):360-74. PubMed ID: 24042242
[TBL] [Abstract][Full Text] [Related]
5. [Blood glucose in chronic schizophrenic patients treated with antipsychotics].
Wetterling T; Schneider B; Weber B
Psychiatr Prax; 2007 Mar; 34(2):76-80. PubMed ID: 17160751
[TBL] [Abstract][Full Text] [Related]
6. Clozapine use in a forensic population in a New South Wales prison hospital.
Martin A; O'Driscoll C; Samuels A
Aust N Z J Psychiatry; 2008 Feb; 42(2):141-6. PubMed ID: 18197509
[TBL] [Abstract][Full Text] [Related]
7. Assessment of monitoring for glucose and lipid dysregulation in adult Medi-Cal patients newly started on antipsychotics.
Barnett M; VonMuenster S; Wehring H; Popish S; McDonald K; Walker VM; Perry P
Ann Clin Psychiatry; 2010 Feb; 22(1):9-18. PubMed ID: 20196978
[TBL] [Abstract][Full Text] [Related]
8. Metabolic risk factor profile associated with use of second generation antipsychotics: a cross sectional study in a Community Mental Health Centre.
Tarricone I; Casoria M; Gozzi BF; Grieco D; Menchetti M; Serretti A; Ujkaj M; Pastorelli F; Berardi D
BMC Psychiatry; 2006 Mar; 6():11. PubMed ID: 16542430
[TBL] [Abstract][Full Text] [Related]
9. Effect of treatment on weight gain and metabolic abnormalities in patients with first-episode psychosis.
Verma S; Liew A; Subramaniam M; Poon LY
Aust N Z J Psychiatry; 2009 Sep; 43(9):812-7. PubMed ID: 19670054
[TBL] [Abstract][Full Text] [Related]
10. Obesity, dyslipidaemias and smoking in an inpatient population treated with antipsychotic drugs.
Paton C; Esop R; Young C; Taylor D
Acta Psychiatr Scand; 2004 Oct; 110(4):299-305. PubMed ID: 15352932
[TBL] [Abstract][Full Text] [Related]
11. Metabolic side effects of second generation antipsychotic agents in antipsychotic-naïve patients: one-month prospective evaluation.
Tarricone I; Serretti A; Gozzi BF; Mandelli L; Grieco D; Mellini L; Biagini S; Berti B; Berardi D
Psychiatry Res; 2008 Jan; 157(1-3):269-71. PubMed ID: 17961714
[TBL] [Abstract][Full Text] [Related]
12. Weight gain and glucose and lipid metabolism disturbances during antipsychotic medication: a review.
Koponen H; Saari K; Savolainen M; Isohanni M
Eur Arch Psychiatry Clin Neurosci; 2002 Dec; 252(6):294-8. PubMed ID: 12563538
[TBL] [Abstract][Full Text] [Related]
13. Clozapine-induced type-2 diabetes mellitus: possible mechanisms and implications for clinical practice.
Tovey E; Rampes H; Livingstone C
J Psychopharmacol; 2005 Mar; 19(2):207-10. PubMed ID: 15728442
[TBL] [Abstract][Full Text] [Related]
14. Adverse effects of atypical antipsychotics.
Wirshing DA
J Clin Psychiatry; 2001; 62 Suppl 21():7-10. PubMed ID: 11584988
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of a computer-based intervention to enhance metabolic monitoring in psychiatry inpatients treated with second-generation antipsychotics.
DelMonte MT; Bostwick JR; Bess JD; Dalack GW
J Clin Pharm Ther; 2012 Dec; 37(6):668-73. PubMed ID: 22845616
[TBL] [Abstract][Full Text] [Related]
16. [Intervals between hospitalisations in schizophrenia patients under antipsychotics in depot-form versus oral second generation antipsychotics].
Gutwinski S; Müller P; Koller M
Psychiatr Prax; 2007 Sep; 34(6):289-91. PubMed ID: 17806015
[TBL] [Abstract][Full Text] [Related]
17. Polymorphisms of the LEP- and LEPR gene and obesity in patients using antipsychotic medication.
Gregoor JG; van der Weide J; Mulder H; Cohen D; van Megen HJ; Egberts AC; Heerdink ER
J Clin Psychopharmacol; 2009 Feb; 29(1):21-5. PubMed ID: 19142102
[TBL] [Abstract][Full Text] [Related]
18. [Glucose abnormalities in a 14-year old patient treated with a second generation antipsychotic].
Lauwers K; de Hert M; de Rijdt L; Peuskens J
Tijdschr Psychiatr; 2006; 48(4):331-5. PubMed ID: 16955998
[TBL] [Abstract][Full Text] [Related]
19. Side effects of second-generation antipsychotics: the experiences, views and monitoring practices of Australian child psychiatrists.
Walter G; DeLaroche A; Soh N; Hunt G; Cleary M; Malhi G; Lambert T; Correll C; Rey J
Australas Psychiatry; 2008 Aug; 16(4):253-62. PubMed ID: 18608172
[TBL] [Abstract][Full Text] [Related]
20. Assessment of a point-of-care metabolic risk screening program in outpatients receiving antipsychotic agents.
Schneiderhan ME; Batscha CL; Rosen C
Pharmacotherapy; 2009 Aug; 29(8):975-87. PubMed ID: 19637951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
